CA-170
Oral PD-L1/PD-L2/VISTA antagonist CA-170
N/A Amino Acids · MW: N/A
Amino Acids
N/A
Molecular Weight
N/A
Half-life
Unknown
Research Score
4.0
Studies
25
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is CA-170?
CA-170 is an orally active small-molecule immuno-oncology agent developed to modulate checkpoint signaling. It is used in research on PD-L1, PD-L2, and VISTA pathway inhibition.
Key Benefits & Mechanisms
oral checkpoint modulation
PD-L1/PD-L2 antagonism
VISTA pathway research
T-cell activation support
Research Summary
CA-170 was developed as an oral checkpoint modulator targeting PD-L1/PD-L2 and VISTA-related signaling. It has reached early clinical evaluation, though definitive efficacy data remain limited.
Related Peptides
Thymalin
Calf Thymus Peptide Fraction (Thymalin)
Thymalin is a thymus-derived peptide preparation, not a single defined sequence, that has been used in Russian literature as an immunomodulator. It is studied for effects on T-cell function, leukocyte recovery, and resilience during infection or recovery states.
Immune SupportThymopentin
L-Arginyl-L-Lysyl-L-Aspartyl-L-Valyl-L-Tyrosine
Thymopentin is a synthetic pentapeptide derived from the active site of thymopoietin. It has been studied as an immunomodulator for supporting T-cell maturation and balancing helper/suppressor responses.
Immune SupportThymogen
L-Glutamyl-L-Tryptophan
Thymogen is a synthetic dipeptide immunomodulator used in Russian literature and markets. It is studied for effects on cellular immunity, recovery from infection, and support of immune balance.
Immune SupportPidotimod
3-L-Pyroglutamyl-L-Thiazolidine-4-Carboxylic Acid
Pidotimod is a synthetic immunostimulatory dipeptide-like compound studied for recurrent respiratory infections and immune dysfunction. It is one of the better-described oral research compounds in the immune-support space.
Immune Support